Pfizer Inc. has announced that it is seeking Emergency Use Authorization (EUA) of its investigational oral antivira...
South Korea-based GI Innovation has inked a biopharmaceutical manufacturing and development based Memorandum o...
Singapore's AUM Biosciences (AUM) has completed of $27 million series A funding round to develop a drug pipeline focused...
CytoReason, an AI company developing computational disease models for discovery and clinical drug development, and Summi...
US-based Mirum Pharmaceuticals, Inc. and Japanese firm Takeda Pharmaceutical have entered into an exclusive licensing ag...
SuperTrans Medical ("STM"), an Australian biopharmaceutical company developing novel antibiotics that target difficult-t...
BC Platforms (BCP), a global leader in genomics research, analytics and global data access, announced a new collabo...
French firm POXEL SA along with its partner, Sumitomo Dainippon Pharma, is launching TWYMEEG (Imeglimin hydro...
What unique initiatives are being taken by the company to connect microbiome with human health? Which are the major ther...
US-based Senhwa Biosciences, Inc. has announced that its novel oral drug, Silmitasertib, has been included in Taiwa...
Healx, the AI-powered, UK-founded global drug discovery company, has entered a partnership with Japan's Ono Pharmace...
Otsuka Pharmaceutical Development & Commercialization, Inc., a subsidiary of Japan-based Otsuka Pharmaceutical, has ...
Hong Kong's Antengene Corporation Limited, a biopharmaceutical company focused on hematology and oncology drugs is ...
China-based startups Insilico Medicine and Westlake Pharma have announced a strategic partnership to jointly develop inn...
Currently, estrogen-receptor-positive breast cancer accounts for about 70% of all breast cancers, with hormone therapy (...
China-based Junshi Biosciences has established a joint venture with Immorna to develop and commercialize new drugs for t...
The global antiviral drugs market growth is stimulated by a growing focus toward therapeutic management ...
South Korean firm Celltrion Group has announced new results from an in vivo efficacy study showing that regdan...
